NCT07195448 Global Research on Appearance in Cancer (GRACE)
| NCT ID | NCT07195448 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Karolinska Institutet |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 800 participants |
| Start Date | 2025-02-10 |
| Primary Completion | 2026-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 800 participants in total. It began in 2025-02-10 with a primary completion date of 2026-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Gaining insight into how weight loss is perceived by persons with advanced cancer, and identifying potential differences related to gender and country of residence, is essential for developing comprehensive, equitable, gender-sensitive recommendations for medical nutrition therapy, with the aim of improving disease outcome.
Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of cancer * Must be able to understand the consent form Exclusion Criteria: \- Expected survival time \< 3 months
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07195448 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07195448 currently recruiting?
Yes, NCT07195448 is actively recruiting participants. Contact the research team at charlotte.goodrose.flores@ki.se for enrollment information.
Where is the NCT07195448 trial being conducted?
This trial is being conducted at Stockholm, Sweden.
Who is sponsoring the NCT07195448 clinical trial?
NCT07195448 is sponsored by Karolinska Institutet. The trial plans to enroll 800 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.